Bunion
Methodology & AI Transparency ⓘ
Bunion Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Bunion is an ICD-10-CM indexed diagnosis (M21.619) within Osteoarthritis, Gout & Joint Pain.
- 2 Real-world patient consensus: Federal ICD-10-CM code M21.619 categorizes Bunion under Osteoarthritis, Gout & Joint Pain.
- 3 Typical cash cost range: Workup highlights for Bunion (M21.619): urate-lowering titration [Bunion M21.619].
- 4 Top reported side effects / signs: Longitudinal Bunion monitoring tracks Weight-Bearing Joint Radiograph [Bunion M21.619] toward Preserved joint-space width (M21.619).
Ask our AI Specialists anything about Bunion
What Is Bunion?
Bunion is an ICD-10-CM indexed diagnosis (M21.619) within Osteoarthritis, Gout & Joint Pain. Clinical evaluation centers on urate-lowering titration [Bunion M21.619] alongside serial Weight-Bearing Joint Radiograph [Bunion M21.619] tracking (Preserved joint-space width (M21.619)) to guide individualized care.
Pathophysiology, Underlying Causes & Clinical Presentation
Mechanistic hallmarks of Bunion (M21.619) center on subchondral bone remodeling [Bunion M21.619]. targeted arthritis & joints interventions aim to normalize Weight-Bearing Joint Radiograph [Bunion M21.619].
Common Symptoms & Clinical Signs
- • Presentation of Bunion (M21.619): activity-related deep aching in Bunion (M21.619: joint pain in)
- • Secondary Bunion clinical sign: brief morning joint in Bunion (M21.619: stiffness)
- • Symptom flares in Bunion correlating with Weight-Bearing Joint Radiograph [Bunion M21.619] deviation outside Preserved joint-space width (M21.619)
- • Functional arthritis & joints impact requiring urate-lowering titration [Bunion M21.619] evaluation (M21.619)
Primary Federal Reference: NIH / National Library of Medicine MedlinePlus Entry ↗
Bunion Diagnostic Classification & Lab Markers
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Code | M21.619 | WHO / CMS ICD-10-CM Clinical Classification |
| Clinical Specialty Hub | Osteoarthritis, Gout & Joint Pain | NIH MedlinePlus Health Topics |
| Diagnostic / Lab Marker: Weight-Bearing Joint Radiograph [Bunion M21.619] | Preserved joint-space width (M21.619) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Serum Uric Acid in Bunion (M21.619: (Gout Target)) | < 6.0 mg/dL (< 5.0 mg/dL with tophi) (M21.619) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: hs-CRP & Erythrocyte in Bunion (M21.619: Sedimentation Rate) | hs-CRP < 1.5 mg/L; ESR < 15 mm/hr (M21.619) | Clinical Reference Target Range |
FDA-Monographed Medications & Public Cash Price Reference for Bunion
Treatment selection for Bunion depends on clinical severity, diagnostic lab results, and medical history. Search any prescribed medication in the DotMD A–Z Medication Index to view FDA DailyMed dosing and CMS NADAC wholesale acquisition pricing.
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Bunion)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| New Insights on Celecoxib-tramadol co-crystal in patients with moderate-to-severe pain following: What a 637-Participant Study Found Celecoxib-tramadol co-crystal was associated with reduced rescue medication use and an acceptable tolerability profile compared with tramadol or celecoxib alone in adults with acute, moderate-to-severe, postoperative pain. Pain practice : the official journal of World Institute of Pain • 2024-11-15 • Phase III Randomized Trial | N = 637 | 93/100 | PMID 38956758 ↗ |
| New Insights on Improvement of Signs and Symptoms of Nonradiographic Axial Spondyloarthritis in: What a 555-Participant Study Found Our findings indicate that secukinumab 150 mg provides significant and sustained improvement in signs and symptoms of nonradiographic axial SpA through 52 weeks. Arthritis & rheumatology (Hoboken, N.J.) • 2021-01-15 • Phase III Randomized Trial | N = 555 | 93/100 | PMID 32770640 ↗ |
| Can This Approach Help? Inside the Latest Research on A phase 3 active-controlled trial of liposomal bupivacaine via sciatic nerve LB 133 mg administered via sciatic nerve block in the popliteal fossa after bunionectomy demonstrated superior and long-lasting postsurgical pain control versus BUPI. Journal of clinical anesthesia • 2024-06-15 • Phase III Randomized Trial | N = 22 | 88/100 | PMID 38340677 ↗ |
Bunion Patient Community & “People Like Me” Threads
Filter Bunion community threads and patient logs by age, biological sex, dosage, and treatment duration.